X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (43) 43
index medicus (36) 36
cardiac & cardiovascular systems (33) 33
humans (30) 30
rabbits (28) 28
female (25) 25
atherosclerosis (22) 22
aged (21) 21
cholesterol (21) 21
middle aged (21) 21
animals (20) 20
macular degeneration (19) 19
diseases of the circulatory system (18) 18
ophthalmology (17) 17
risk factors (16) 16
hypercholesterolemia (14) 14
disease models, animal (13) 13
medicine, general & internal (13) 13
abridged index medicus (12) 12
cardiovascular diseases (12) 12
sclera (12) 12
surgery (12) 12
degeneração macular (11) 11
diet (11) 11
aterosclerose (10) 10
cardiovascular disease (10) 10
choroid (10) 10
health risk assessment (10) 10
heart attacks (10) 10
myocardial infarction (10) 10
myocardial revascularization (10) 10
coelhos (9) 9
colesterol (9) 9
double-blind method (9) 9
hypertension (9) 9
stroke (9) 9
acute coronary syndromes (8) 8
antioxidants (8) 8
diabetes (8) 8
hypercholesterolemia - etiology (8) 8
hypercholesterolemia - metabolism (8) 8
immunohistochemistry (8) 8
macrophages (8) 8
mortality (8) 8
patients (8) 8
treatment outcome (8) 8
cardiology (7) 7
clinical trials (7) 7
esclera (7) 7
models, animal (7) 7
revascularização miocárdica (7) 7
adult (6) 6
antioxidantes (6) 6
cardiovascular diseases - mortality (6) 6
cerebral infarction (6) 6
diabetes mellitus (6) 6
dieta (6) 6
heart failure (6) 6
hypercholesterolemia - pathology (6) 6
incidence (6) 6
myocardial-infarction (6) 6
prevention (6) 6
research (6) 6
aged, 80 and over (5) 5
aspirin (5) 5
brazil (5) 5
cardiovascular (5) 5
cardiovascular diseases - prevention & control (5) 5
carotenoids (5) 5
choroid - metabolism (5) 5
choroid - pathology (5) 5
coroide (5) 5
coronary artery disease (5) 5
drug dosages (5) 5
drug therapy, combination (5) 5
follow-up studies (5) 5
free radicals (5) 5
hemorrhage - chemically induced (5) 5
lutein (5) 5
modelos animais (5) 5
myocardial infarction - drug therapy (5) 5
myocardial infarction - epidemiology (5) 5
myocardial infarction - prevention & control (5) 5
platelet aggregation inhibitors - adverse effects (5) 5
platelet aggregation inhibitors - therapeutic use (5) 5
randomized controlled trials as topic (5) 5
risk (5) 5
sclera - metabolism (5) 5
sclera - pathology (5) 5
severity of illness index (5) 5
supplementary feeding (5) 5
therapy (5) 5
thrombosis (5) 5
acute coronary syndrome - drug therapy (4) 4
age factors (4) 4
angina pectoris (4) 4
anoxia (4) 4
anticoagulants (4) 4
aspirin - therapeutic use (4) 4
atrial fibrillation (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ... and COMPASS Investigators and COMPASS investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
by Devereaux, P.J and Devereaux, P J and Duceppe, Emmanuelle and Guyatt, Gordon and Tandon, Vikas and Rodseth, Reitze and Biccard, Bruce M and Xavier, Denis and Szczeklik, Wojciech and Meyhoff, Christian S and Vincent, Jessica and Franzosi, Maria Grazia and Srinathan, Sadeesh K and Erb, Jason and Magloire, Patrick and Neary, John and Rao, Mangala and Rahate, Prashant V and Rahate, Prashant and Chaudhry, Navneet and Chaudhry, Navneet K and Mayosi, Bongani and Mayosi, Bogani and de Nadal, Miriam and Iglesias, Pilar Paniagua and Berwanger, Otavio and Villar, Juan Carlos and Botto, Fernando and Eikelboom, John and Eikelboom, John W and Sessler, Daniel I and Kearon, Clive and Pettit, Shirley and Sharma, Mukul and Sharma, Ambika and Sharma, Mike and Connolly, Stuart and Connolly, Stuart J and Bangdiwala, Shrikant I and Rao-Melacini, Purnima and Hoeft, Andreas and Yusuf, Salim and Pogue, Janice and Di Diodato, Sara and Gasic, Zora and Mastrangelo, Louise J and Molnar, Sarah H and Swanson, Jennifer L and Tosh, Makayla L and Wells, Jennifer R and Wells, George A and Diaz, Rafael and Chow, Clara K and Gonzales, Beatriz and Vásquez, Skarlet and Jansky, Petr and Dušek, Radovan and Coriat, Pierre and Wittmann, Maria and Yonga, Gerald and Mathur, Nandini and Seletti, Elena and Malaga, German and Tumanan-Mendoza, Bernadette A and Tagle, Maria Pamela A and Alonso-Coello, Pablo and Popova, Ekaterine and Shields, Martin O and Shields, Martin and Le Manach, Yannick and Moayyedi, Paul and van Zanten, Sander and Fleischmann, Edith and Garg, Amit and Karaye, Kamilu and McFalls, Edward and Sigamani, Alben and Belley-Côté, Emilie and Biedroń, Grzegorz and Borges, Flavia and Frosi Stella, Steffan and Haarmark Nielsen, Christian and Leong, Darryl P and Spence, Jessica and Tran, Allen and Wawrzycka-Adamczyk, Katarzyna and Yang, Stephen S and Yung, Terence and Wyse, D. George and Cheng, Davy and Johnstone, David E and Joseph, Philip and Patel, Ameen and Gregus, Krysten and Lawrence, Kelly and Doharris, Lindsay and Conen, David and Cheung, Jason and Douketis, Jim and Wright, Douglas and ... and MANAGE Investigators
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10137, pp. 2325 - 2334
Myocardial injury after non-cardiac surgery (MINS) increases the risk of cardiovascular events and deaths, which anticoagulation therapy could prevent.... 
DEFINITION | MORTALITY | MEDICINE, GENERAL & INTERNAL | THERAPY | EVENTS | RIVAROXABAN | DOUBLE-BLIND | ELEVATION | ACUTE CORONARY SYNDROMES | ASPIRIN | Troponin - drug effects | Dabigatran - adverse effects | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Dabigatran - administration & dosage | Humans | Stroke - complications | Male | Hemorrhage - prevention & control | Peripheral Arterial Disease - complications | Venous Thromboembolism - drug therapy | Antithrombins - pharmacology | Venous Thromboembolism - prevention & control | Aged, 80 and over | Female | Dabigatran - pharmacology | Troponin - metabolism | Omeprazole - therapeutic use | Stroke - prevention & control | Placebo Effect | Omeprazole - administration & dosage | Perioperative Period - mortality | Hemorrhage - complications | Peripheral Arterial Disease - drug therapy | Treatment Outcome | Stroke - drug therapy | Proton Pump Inhibitors - therapeutic use | Peripheral Arterial Disease - prevention & control | Thrombosis - pathology | Hemorrhage - drug therapy | Myocardial Infarction - drug therapy | Aged | Clinical trials | Anesthesia | Care and treatment | Analysis | Cardiac patients | Heart | Myocardial infarction | Cardiac arrhythmia | Heart attacks | Embolisms | Heart surgery | Risk | Cardiovascular disease | Family medical history | Bleeding | Randomization | Motivation | Safety engineering | Surgery | Amputation | Safety | Thromboembolism | Heart diseases | Anticoagulants | Cerebral infarction | Stroke | Aspirin | Complications | Mortality | Health risks | Patients | Thrombosis | Omeprazole | Sepsis | Infarction | Adults | Cardiovascular diseases | Health risk assessment | Factorial design | Index Medicus | Abridged Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 02/2017, Volume 184, pp. 88 - 96
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article